PURE Bioscience, Inc. (PURE) Reports Q4 Loss of $0.05
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Join SI Premium – FREE
PURE Bioscience, Inc. (NASDAQ: PURE) reported Q4 EPS of ($0.05), versus ($0.05) reported last year. Revenue for the quarter came in at $244 thousand, versus $324 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
- FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
